loading page

THE IMMUNOMODULATORY POTENTIALS OF INTERLEUKIN-27 IN AIRWAY ALLERGIES AND COVID-19
  • +2
  • Abdollah Jafarzadeh,
  • Maryam Nemati,
  • Sara Jafarzadeh,
  • Prashant Chauhan,
  • BHASKAR SAHA
Abdollah Jafarzadeh
Kerman University of Medical Sciences
Author Profile
Maryam Nemati
Rafsanjan University of Medical Sciences
Author Profile
Sara Jafarzadeh
Kerman University of Medical Sciences
Author Profile
Prashant Chauhan
National Centre For Cell Science
Author Profile
BHASKAR SAHA
National Centre For Cell Science
Author Profile

Abstract

Allergic airway disorders such as asthma and allergic rhinitis are mainly caused by inhaled allergen-induced improper activation and responses of immune- and non-immune cells. One important response is the production of IL-27 by macrophages and dendritic cells (DCs) during the early stage of airway allergies. IL-27 exerts powerful modulatory influences on the cells of innate immunity [e.g., neutrophils, eosinophils, mast cells, monocytes, macrophages, dendritic cells (DCs), innate lymphoid cells (ILCs), natural killer (NK) cells and NKT-cells)] and adaptive immunity (e.g. Th1-, Th2-, Th9-, Th17-, regulatory T-, CD8+ cytotoxic T- and B-cells). The IL-27-mediated signaling pathways may be modulated to attenuate asthma and allergic rhinitis. In this review, a comprehensive discussion concerning the roles carried out by IL-27 in asthma and allergic rhinitis was provided, while evidences are presented favouring the use of IL-27 in the treatment of airway allergies.